Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.30 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.30 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.30 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15075698 | 0.80 | EPHX2 (0.39) | EPHX2GFER | |
| SCHEMBL15075645 | 0.79 | ALDH1A1 (0.39) | EPHX2GFER | |
| SCHEMBL19036772 | 0.79 | ALDH1A1 (0.36) | — | |
| SCHEMBL18819656 | 0.75 | EPHX2 (0.35) | EPHX2GFER | |
| SCHEMBL18819094 | 0.74 | EPHX2 (0.34) | EPHX2GFER | |
| SCHEMBL19036508 | 0.72 | KDM4E (0.40) | — | |
| SCHEMBL18819443 | 0.72 | EPHX2 (0.41) | EPHX2GFER | |
| SCHEMBL18819722 | 0.70 | EPHX2 (0.37) | EPHX2GFER | |
| SCHEMBL8952584 | 0.60 | POLB (0.33) | EPHX2 | |
| SCHEMBL21711061 | 0.60 | PER2 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130165427-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES | HYDRA BIOSCIENCES, INC. (US) | 2013-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165427-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES | ELANE, CASP3, MMP8 | EPHX2 838/4885GFER 1214/4885GRIA1 3378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.